4.2 Article

Systemic lupus erythematosus - 2006 update

Journal

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
Volume 12, Issue 1, Pages 37-40

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.rhu.0000200420.67262.04

Keywords

-

Categories

Funding

  1. NCRR NIH HHS [M01 RR00052] Funding Source: Medline
  2. NIAMS NIH HHS [AR 43737] Funding Source: Medline

Ask authors/readers for more resources

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease most frequently presenting as photosensitive rash, polyarthritis, or renal disease. It represents the tip of the iceberg of autoimmunity. Positive antinuclear antibody (ANA) occurs in 10% or more of normal young women (but 96% or more of patients with SLE). Localized autoimmune disorders such as autoimmune thyroid disease, juvenile-onset diabetes mellitus, Sjogren syndrome, and others Occur in approximately 10% of the population. Systemic autoimmunity, however, is rarer. Undifferentiated connective tissue disease (UCTD) may occur in as many as 5% of Women, but usually does not progress over time into true SLE. SLE remains one of the most fascinating and enigmatic of the autoimmune diseases and a constant challenge to rheumatologists and other specialists.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available